Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
98
98 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- REGN4336Phase 22 trials
Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- vudalimabPhase 22 trials
Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer
- ZalifrelimabPhase 22 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- ZEN003694ZEN-3694Phase 22 trials
Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer
- ACE-86225106Phase 21 trial
Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation
- ADI-212Phase 21 trial
Adicet Therapeutics · Prostate Cancer Metastatic
- AMO959BY1298, BY101298Phase 21 trial
Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
- AMXI-5001Phase 21 trial
AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer
- AS1986NSPhase 21 trial
Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging
- ASP5541PRL-02Phase 21 trial
Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
- AZD0516Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD0754Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD6621Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD8359Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD9750Phase 21 trial
AstraZeneca · Prostate Cancer
- CC-38Phase 21 trial
CuraCell TX AB · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
- CRG-150Phase 21 trial
CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer
- Debio 4228Phase 21 trial
Debiopharm International SA · Prostate Cancer
- ETX-19477Phase 21 trial
858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer
- FG-3246FOR46Phase 21 trial
Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer
- FOG-001Phase 21 trial
Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor
- Ga-68-NGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- GDC-1261Phase 21 trial
Roche (Genentech) · Advanced Prostate Cancer, Metastatic Prostate Cancer
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- HP518Phase 21 trial
Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer
- HRS-1738Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer
- INV-9956Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- Lu-177-DGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- MHB048CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- preferred combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
- REGN15505Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN21353Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC
- RS-113Phase 21 trial
R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer
- RV001VPhase 21 trial
RhoVac APS · Prostate Cancer Recurrent
- RYZ711Phase 21 trial
RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- selected combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
- SHR-4394Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SHR3680Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- SV-102Phase 21 trial
Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer
- SX-682Phase 21 trial
Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer
- TB511Phase 21 trial
Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer
- TQB3201Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer
- TT-10Phase 21 trial
Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer
- TY-302Phase 21 trial
TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.